The human adaptation of influenza A viruses is critically governed by the binding specificity of the viral surface hemagglutinin (HA) to long (chain length) ␣2-6 sialylated glycan (␣2-6) receptors on the human upper respiratory tissues. A recent study demonstrated that whereas the 1918 H1N1 pandemic virus, A/South Carolina/1/1918 (SC18), with ␣2-6 binding preference transmitted efficiently, a single amino acid mutation on HA resulted in a mixed ␣2-3 sialylated glycan (␣2-3)/␣2-6 binding virus (NY18) that transmitted inefficiently. To define the biochemical basis for the observed differences in virus transmission, in this study, we have developed an approach to quantify the multivalent HA-glycan interactions. Analysis of the molecular HA-glycan contacts showed subtle changes resulting from the single amino acid variations between SC18 and NY18. The effect of these changes on glycan binding is amplified by multivalency, resulting in quantitative differences in their long ␣2-6 glycan binding affinities. Furthermore, these differences are also reflected in the markedly distinct binding pattern of SC18 and NY18 HA to the physiological glycans present in human upper respiratory tissues. Thus, the dramatic lower binding affinity of NY18 to long ␣2-6 glycans, as against a mixed ␣2-3/6 binding, correlates with its inefficient transmission. In summary, this study establishes a quantitative biochemical correlate for influenza A virus transmission.
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hemagglutinin ͉ multivalency ͉ sialylated glycans T he Spanish influenza pandemic of 1918 caused by the H1N1 subtype virus resulted in Ϸ20 million to 50 million deaths worldwide (1) . The emergence of avian influenza H5N1 viruses that are able to infect humans (Ͼ300 known cases) and produce a high mortality rate (Ϸ200 deaths) has raised serious global health concerns. Significantly, adaptation of these viruses for efficient human-human transmission could result in a new influenza pandemic, a public health disaster of tragic proportions.
The critical step in the host infection of influenza viruses is the binding of their viral surface hemagglutinin (HA) to sialylated glycan receptors on the epithelial cell surface of the host organism (2-6). The evolution of pandemic viruses involves crossing-over of avian influenza viruses (natural host) to humans and adaptation to the human host for subsequent infection and human-human transmission (2, 7) . This cross-over is believed to involve mutations in HA that switch its glycan receptor preference from ␣2-3 sialylated (␣2-3) to ␣2-6 sialylated (␣2-6) glycans found in abundance in human upper respiratory epithelia (3) (4) (5) 8) . The human upper respiratory tract ␣2-6 receptor adaptation of HA is a critical step in permitting the viruses to infect and efficiently replicate in these tissues, leading to rapid humanhuman transmission (8). Several studies have been performed to elucidate the distribution of glycans in human upper respiratory tissues (4, (8) (9) (10) . We recently demonstrated that human upper airways express a diversity of ␣2-6 structures with a predominant expression of long oligosaccharides (11) . More importantly, we observed that both ␣2-3 and short ␣2-6 glycan structures adopt a distinct, narrow cone-like topology, whereas long ␣2-6 glycans adopt a flexible umbrella-like topology. Human-adapted H1 and H3 HA demonstrated high-affinity binding specificity to long ␣2-6 glycans that are expressed in the human upper respiratory epithelium. The classification of HA glycan specificity in terms of the glycan topology instead of the linkage has permitted us to distinguish the observed ␣2-3 and ␣2-6 binding of avian HAs from that of the ␣2-6 binding of human-adapted HA. Based on these observations, we postulated that HA specificity to ␣2-6 glycan receptors with distinct topology is the critical determinant for efficient human adaptation of HA (11) .
The relationship between HA mutations, which lead to a change in glycan receptor preference and transmissibility of the prototypic 1918 H1N1 pandemic virus [A/South Carolina/1/1918 (SC18)] has been investigated by using the ferret model (12) . Recently, Tumpey et al. (12) demonstrated that the SC18 with ␣2-6 binding preference transmitted efficiently but a single amino acid HA mutation (SC18 ϩ one mutation) resulted instead in a mixed ␣2-3/␣2-6 binding virus (NY18) that transmitted inefficiently. Furthermore, a second HA mutation (NY18 ϩ one mutation) resulted in an ␣2-3 binding virus (AV18) that did not transmit. This model system is ideally suited to study transmissibility purely based on HA mutations, as all other genes are identical in the different viruses. These remarkable differences in virus transmission as the result of a single amino acid mutation on HA, in turn, raise important questions about HA-glycan specificity in the context of glycan topology not only for human adaptation but also for efficient transmission.
In this study, we have developed a quantitative framework to investigate HA-glycan specificity to explain the observed differences in the transmissibility of the 1918 pandemic influenza A viruses. The differences in the molecular HA-glycan contacts caused by the single amino acid variations were investigated by using H1 HA-glycan cocrystal structures (13) . The effects of these subtle differences on the multivalent HA-glycan interactions were captured by using a quantitative glycan-binding assay to establish the relative glycan binding affinities of the HAs. The physiological relevance of the differences in the HA-glycan binding affinities was investigated by using HA binding to human upper respiratory tissues. Taken together, this approach establishes a quantitative biochemical correlation between influenza virus HA-glycan binding and virus transmission.
Results
Molecular Interactions of SC18, NY18, and AV18 HAs with ␣2-3 and ␣2-6. Based on analysis of HA-glycan cocrystal structures, the HA-glycan interactions are characterized by using a cone-like and an umbrella-like glycan topology (11) . The x-ray crystal structure of SC18 HA has been solved (13, 14) , but the cocrystal structure of this HA with sialylated glycans remains unsolved. The structures of NY18 and AV18 HA were obtained by making the single Asp-225-Gly (for NY18 HA) and the additional NY18 ϩ Asp-190-Glu mutation for AV18 in silico. The cocrystal structures of the related A/Swine/Iowa/15/30 (ASI30) and A/Puerto Rico/8/34 (APR34) H1N1 HAs with ␣2-3 and ␣2-6 glycans (13) enabled the investigation of molecular interactions between SC18, NY18, and AV18 with ␣2-3 and ␣2-6 oligosaccharides.
The umbrella-like topology is preferred by longer ␣2-6 oligosaccharides (tetrasaccharide and higher). The LSTc pentasaccharide [N-acetylneuraminic acid (Neu5Ac) ␣2-6Gal␤1-4 Nacetylglucosamine (GlcNAc) ␤1-3Gal␤1-4Glc] used in the APR34 and ASI30 HA-␣2-6 cocrystal structures represents this long ␣2-6. Superimposition of these cocrystal structures and SC18 HA demonstrated that the contacts with long ␣2-6 oligosaccharide are divided into two regions. The base region involves contacts with the Neu5Ac␣2-6Gal␤1-motif, and the extension region involves contacts with the -GlcNAc␤1-3Gal␤1-4Glc␤1-motif. A highly conserved set of amino acids (Tyr-95, Ser/Thr-136, Trp-153, Thr-155, His-183, Leu/Ile-194) are involved in anchoring the Neu5Ac (Fig. 1 ). In the case of APR34 and SC18 HAs, both the backbone carbonyl oxygen and side chain of Asp-225 are positioned to interact with the Gal sugar in the base region. On the other hand, only the carbonyl oxygen of Gly-225 in ASI30 HA is positioned to interact with this Gal (Fig. 1) . Highly conserved Lys-222 and Gln-226 are also positioned to interact with the base region. The critical amino acids involved in contacts with the extension region are Asp-190 (in SC18 and ASI30 HA), in APR34 HA). NY18 HA, the Asp-225-Gly mutant of SC18, shares an almost identical glycan binding site with that of ASI30 HA and therefore lacks the extra contact provided by the side chain of Asp-225 with Gal in the base region. In contrast, AV18 (the Asp-190-Glu/ Asp-225-Gly double mutant of SC18) lacks the critical contacts provided by both Asp-225 and Asp-190 to the base and extension regions, respectively. Among SC18, NY18, and AV18 HAs, SC18 HA provides the best contacts with the long ␣2-6 in the umbrella-like topology followed by NY18 HA.
Distinct from the umbrella-like topology, the cone-like topology can be adopted by both ␣2-3 and ␣2-6 [preferentially by short trisaccharide units such as Neu5Ac␣2-6Gal␤1-4Glc (or GlcNAc)]. Unlike the two distinct regions of HA contacts found with the umbrella-like topology, the contacts with the cone-like topology primarily involve substitutions that center around a trisaccharide Neu5Ac␣2-3/6Gal␤1-3/4Glc (or GlcNAc) motif as observed in the HA-␣2-3 cocrystal structures. Specifically, Glu-190 and Gln-226, which are highly conserved across various avian HAs, are critically involved in making optimal contacts with the cone-like topology (Fig. 1 ). This observation is corroborated further by the disordered sugars beyond Neu5Ac in the ASI30 HA-␣2-3 cocrystal structure because Asp instead of Glu at 190 in this HA lacks the contact with the ␣2-3. Superimposition of AV18 and APR34 HA, which both contain these critical amino acids, shows that AV18 HA makes optimal contacts with the cone-like glycan topology. Both SC18 and NY18 HAs lack the critical Glu-190 residue, and therefore their contacts with the cone-like glycan topology are less optimal when compared with AV18 HA.
Dose-Dependent Direct HA Binding to Representative ␣2-3 and ␣2-6
Oligosaccharides. Novel glycan array platforms have been developed to investigate HA-glycan interactions (15, 16) . These arrays have provided important insights into ␣2-3 versus ␣2-6 binding specificity of various WT and mutant HAs. In these glycan array studies, high and low binding signals to the glycans within a single assay using saturating HA concentrations determine the glycan binding preference for a given HA. It is generally accepted that the glycan binding affinity for a single binding site on any glycan binding protein (such as a lectin) is low (typically in the high micromolar to millimolar range). Because each HA unit is a trimeric protein, there are three glycan binding sites per unit (5) . In addition, multiple HA units assemble on a virus surface. The glycan binding sites within a HA unit and the spatial arrangement of multiple HA units across a virus surface could play an important role in multivalent HAglycan interactions. The concentration of the HA units relative to the glycans consequently will critically govern HA-glycan binding specificity.
To understand differences in the glycan binding specificity of SC18, NY18, and AV18 HAs for a specific spatial arrangement of the HA units and the glycans, systematic direct HA binding studies on a plate array were performed (see Materials and Methods). Minimal binding signals were observed for SC18 HA in the sequential ELISA-type binding assay (Fig. 2) . Given that glycan spacing and HA unit size limits HA binding to only a single glycan in this assay, the binding signals are consistent with the anticipated weak affinity of the HA unit to a single glycan. The precomplexation assay with SC18 HA, where four HA units are locked spatially, instead resulted in at least an 8-fold increase in the binding to the long ␣2-6 glycan (Fig. 2) . This dramatic increase in the binding signal underscores the role that the spatial arrangement of multiple HA units plays in enhancing glycan binding.
Dose-dependent direct binding assays by serial dilution of the precomplexed SC18, NY18, and AV18 HAs were performed to establish their relative glycan binding affinities (Fig. 3) . The cooperativity factor n and the apparent binding constant HA showed the reverse trend with almost no ␣2-6 binding and high ␣2-3 binding affinity (K d Ј ϭ 5 pM). On the other hand, whereas the long ␣2-6 binding of NY18 HA was almost identical to that of SC18 HA at saturating HA concentrations (Fig. 3) , the binding affinity to long ␣2-6 (K d Ј ϭ 6 nM) was significantly lower than that of SC18 HA. These observations correlate with the differences in molecular interactions of SC18, NY18, and AV18 with ␣2-3 and ␣2-6 oligosaccharides.
Binding of SC18 and NY18 to Human Upper Respiratory Tissues. The remarkable differences in the binding affinities of ␣2-6 and ␣2-3 (from above) of SC18 and NY18 HA render them ideal lectinlike probes for investigating HA binding to diverse physiological glycans present in human upper respiratory tissues. Human tracheal sections were used to explore the binding pattern of SC18 and NY18 HA to the physiological glycans. Although both SC18 and NY18 bind to the apical side of the trachea (Fig. 4) , the pattern and distribution of the tissue binding of the two HAs differ significantly. Notably, SC18 binding to the apical side of the trachea appears more restricted when compared with the well distributed binding of NY18. NY18 HA also shows binding to the internal region of the trachea (that are known to express ␣2-3 glycans), consistent with its direct binding to ␣2-3 glycans (Fig. 3) . To further investigate the differences in apical binding of SC18 and NY18 HAs, costaining of tracheal tissues were performed with these HAs and Jacalin (a marker for goblet cells). This costaining demonstrated that whereas SC18 HA predominantly binds to goblet cells (expressing ␣2-6), NY18 HA showed minimal binding to these cells (Fig. 5) .
Discussion
Glycan arrays comprising many distinct oligosaccharide motifs have been used to investigate the glycan binding of WT and mutant H1, H3, and H5 HAs (15) (16) (17) . Despite these advances, interpretation of glycan receptor specificity that leads to human adaptation and transmission has remained challenging. This is caused, in large part, by a general notion that glycan-protein interactions are relatively weak and nonspecific. Consequently, the glycan binding specificity for HA has largely been established by using very high protein concentrations. High HA concentration may be useful to establish binders versus nonbinders but it imposes serious limitations on defining appropriate quantitative measurements to establish relative glycan binding affinities of HA. For example, at high concentrations, the typically used first-order binding kinetics assumptions (pertaining to HA/ glycan ratio) would not be satisfied. To accurately quantify the relative glycan binding affinities between HAs, it is essential to be at the ''appropriate'' HA concentration range. Several key parameters, which include the spatial arrangement of multiple HA units, the surface glycan density (such as on a plate versus printed array), and the ratio of HA to glycan need to be taken into account when determining the appropriate HA concentration range for a given glycan array assay. Furthermore, comparing the glycan binding of different HAs at any single concentration point does not accurately capture the binding specificity that is established over a concentration range. In this study, the specific spatial arrangement of the glycans (spacing imposed by biotin-avidin system) and the HA (imposed by precomplexation of HA units) in tandem with the dose-dependent glycan binding assay was able to overcome these challenges. Most importantly, the concentration range used to determine the binding affinity parameters (n and K d Ј) is such that the glycan is in excess of the HA as would be expected in physiological conditions. This point is important for not only HA-glycan interactions, but also for glycan binding proteins in general. The observations presented in this study call for the reconsideration of the published results on glycan specificity based on high protein concentrations. The Relative binding affinities of SC18, NY18, and AV18 HAs to representative long ␣ 2-3 and ␣ 2-6 glycans. n.b. indicates no binding. The parameters n and K dЈ were determined as described in Materials and Methods and elaborated in SI Fig. 7 . These parameters were obtained to purely quantify the relative binding affinities of the HAs, and hence their absolute values should be viewed only in this context. approach described here can be readily extended to any glycan array platform to quantitatively investigate protein-glycan interactions.
At high HA concentrations, SC18 and NY18 HA display no differences in their binding to long ␣2-6 glycan. The only difference between SC18 and NY18 at saturating HA concentrations is the additional binding to ␣2-3 glycans for NY18 HA. As the ␣2-3 binding of SC18, NY18, and AV18 shows inverse correlation with the transmissibility, a probable conclusion from these data are that the loss of ␣2-3 binding specificity is a critical factor for transmission. However, A/Texas/36/91 (TX91), a mixed ␣2-6/␣2-3 binding virus similar to NY18, transmitted efficiently in ferrets (12) . The dose-dependent direct binding of TX91 and A/Moscow/10/99 H3N2 (Mos99; a mixed ␣2-6/␣2-3 binding human-adapted H3 HA) compared with that of SC18 and NY18 clearly shows that the high affinity binding to long ␣2-6 glycan is a common feature for SC18, Tx91, and Mos99, but not for NY18 (Fig. 3) . This common feature of specificity to long ␣2-6 glycan is independent of specificity to ␣2-3 glycans. Thus, this study corroborates the observation that the high-affinity binding to long ␣2-6 glycans, which are extensively expressed in the upper respiratory tissues, is a critical determinant not only for HA human adaptation, but also for influenza virus transmission.
The critical role of the long ␣2-6 glycans as physiological targets for influenza A virus infection and transmission also highlights the role of biosynthetic enzymes involved in synthesizing these glycans in addition to the ␣2-6 sialyltransferases. Specifically, the ␤4GalTs (␤1-4 galactosyltransferases) and ␤3GlcNAcTs (␤1-3 N-acetylglucosaminyl transferases) are involved in synthesizing multiple lactosamine repeats characteristic of long ␣2-6 glycans. The regulation of the expression of these glycosyltransferases would not only play a critical role in the viral tropism but it would also enable better selection pressure strategies to understand the evolution of mutations in HA that would lead to efficient human adaptation and human-to-human transmission.
Differential binding of SC18 and NY18 to the diverse physiological glycans present in the human upper respiratory tissues further substantiates the direct binding studies. The narrow binding of SC18 to goblet cells motivates future investigations into the cellular tropism of human-adapted viruses. This observation is consistent with a report by Matrosovich et al. (18) , who demonstrated that human-adapted H1 and H3 virus strains preferentially infect nonciliated cells and avian viruses preferentially infect ciliated cells. They also suggested that such differences in the cellular tropism of the viruses could explain the differences in their efficiency of human-human transmission. Furthermore, the binding of SC18 HA to goblet cells taken together with its long ␣2-6 binding specificity correlates with its localized binding to the apical side of the tracheal tissue and also suggests the expression of long ␣2-6 glycans in the goblet cells. On the other hand, SNA-I that binds to both short and long ␣2-6 glycans shows more extensive apical side tracheal binding (11) . Therefore, SC18 HA could potentially be a more effective lectin-like probe for investigating the distribution of long ␣2-6 as compared with SNA-I.
In conclusion, we have shown how quantitative differences in the HAs binding to long ␣2-6 glycans correlate with the observed differences in viral transmission. The study of the 1918 viruses varying only in their HA genes and having different transmission efficiencies served as a good model system for establishing this correlate. Given the potential threat of a pandemic from currently circulating avian H5N1 viruses, the approach presented here can aid in the screening of H5N1 HA mutants that could lead to human adaptation and transmission of these deadly viruses.
Materials and Methods
Cloning, Baculovirus Synthesis, Expression, and Purification of HA. The soluble form of HA was expressed by using the baculovirus expression vector system (BEVS). SC18 baculovirus [generated from pAcGP67-SC18-HA plasmid (14, 15) ] was a gift from James Stevens (Centers for Disease Control). pAcGp67-NY18-HA and pAcGp67-AV18-HA plasmids were generated from pAcGP67-SC18-HA by [Asp-225-Gly] and [Asp-190 -Glu, Asp-225-Gly] mutations respectively. Mutagenesis was carried out with the QuikChange multi site-directed mutagenesis kit (Stratagene). The primers used for mutagenesis were designed by using the web-based program, PrimerX (http://bioinformatics.org/ primerx) and synthesized by IDT DNA Technologies. NY18 and AV18 baculoviruses were created from pAcGP67-NY18-HA and pAcGP67-AV18-HA constructs by using the Baculogold system (BD Biosciences) according to the manufacturer's instructions. The baculoviruses were used to infect 300-ml suspension cultures of Sf9 cells (BD Biosciences) cultured in BD BaculoGold Max-XP Insect Cell medium (BD Biosciences). These cultures were monitored for signs of infection and harvested 4 -5 days postinfection. BEVS produces trimeric HA, which provides multivalent binding to glycans. The soluble form of HA was purified from the supernatant of infected cells as described (14) . Briefly, the supernatant was concentrated by using Centricon Plus-70 centrifugal filters (Millipore), and the trimeric HA was recovered from the concentrated cell supernatant by using affinity chromatography with columns packed with Ni-NTA beads (Qiagen). Eluting fractions that contained HA were pooled and dialyzed overnight with a 10 mM Tris⅐HCl, 50 mM NaCl buffer (pH 8.0). Ion exchange chromatography was then performed on the dialyzed samples by using a Mono-Q HR10/10 column (GE Healthcare). The fractions containing HA were pooled together and subjected to ultrafiltration by using Amicon Ultra 100 K NMWL membrane filters (Millipore). The protein was then concentrated and reconstituted in PBS. The purified protein was quantified by using Bio-Rad's protein assay.
Dose-Dependent Direct Glycan Binding of HA.
To investigate the multivalent HA-glycan interactions a streptavidin plate array comprising representative biotinylated ␣2-3 and ␣2-6 (short and long) was used. The spatial arrangement of the glycans in the wells of this plate array favors binding to only one of the three HA monomers in the HA unit. The glycan spacing and the HA unit size limit binding of the HA unit to a single glycan in the ELISA-type binding assay, which involves the sequential application of HA unit, primary and secondary antibodies (see below). Conversely, the precomplexation of HA units (see below) with primary and secondary antibodies (HA/primary/secondary ϭ 4:2:1 ratio) facilitates a specific spatial arrangement of four HA units. This precomplexed unit therefore enabled the investigation of the effects of the relative spatial positioning of multiple HA units on the glycan binding affinity via multivalency.
Streptavidin-coated high binding capacity 384-well plates (Pierce) were loaded to the full capacity of each well by incubating the well with 50 l of 2.4 M biotinylated glycans overnight at 4°C. The biotinylated glycans [␣2-3 sialylated lactosamine (3ЈSLN), ␣2-6 sialylated lactosamine (6'SLN), 3ЈSLN-LN,   Fig. 5 . Human tracheal costaining of SC18 and NY18 HA with Jacalin. The apical side of the tracheal epithelia is indicated by white arrows. The distinct apical binding patterns of SC18 and NY18 (in Fig. 4) are further elaborated by costaining the HAs (red) with Jacalin (green), a marker for goblet cells. The images were taken at ϫ25 magnification, and representative regions of the apical side are enlarged for clarity. The significant costain of SC18 HA with Jacalin (yellow) indicates that SC18 HA predominantly binds to goblet cells on the apical side of the epithelia. On the other hand, the binding pattern of NY18 HA has minimal overlap with that of Jacalin, indicating that it does not bind to goblet cells on the apical side of tracheal tissue.
6 'SLN-LN and 3ЈSLN-LN-LN] were obtained from the Consortium of Functional Glycomics (www.functionalglycomics.org) through their resource request program. LN corresponds to lactosamine (Gal␤1-4GlcNAc) and 3ЈSLN and 6'SLN correspond to Neu5Ac␣2-3 and Neu5Ac␣2-6 linked to LN, respectively. Excess glycans were removed through extensive washing with PBS. For the ELISA-type sequential binding, the glycan-coated wells were incubated for 2 h with HA at a concentration of 40 g/ml (typical high concentrations used in glycan array experiments) in PBS containing 1% BSA and subsequently washed extensively with PBS-Tween followed by PBS. This process was followed by incubation with the primary antibody (mouse anti 6ϫ His tag IgG) at a concentration of 5 g/ml in PBS containing 1% BSA for 3 h at room temperature and repeating the above wash steps. The wells were finally incubated with a 2 g/ml solution of the secondary antibody (HRP-conjugated goat anti mouse IgG) for 1 h at room temperature. In the case of dose-dependent precomplexed HA experiments, a stock solution containing appropriate amounts of His-tagged HA protein, primary antibody (mouse anti 6ϫ His tag IgG) and secondary antibody (HRP-conjugated goat anti mouse IgG (Santa Cruz Biotechnology) in the ratio 4:2:1 and incubated on ice for 20 min. Appropriate amounts of precomplexed stock HA were diluted to 250 l with 1% BSA in PBS. Fifty microliters of this precomplexed HA was added to each of the glycan-coated wells and incubated at room temperature for 2 h followed by the above wash steps. The binding signal was determined based on HRP activity by using Amplex Red Peroxidase Assay (Invitrogen) according to the manufacturer's instructions. Appropriate negative controls were included, and all assays were performed in triplicate.
Previously, dose-dependent direct binding assays using the above precomplexation were performed to establish binding specificity of human-adapted HAs to long ␣2-6 (11). These assays were performed by incubating different concentrations of HA with appropriate concentrations of primary and secondary antibodies (to achieve the 4:2:1 ratio stated above). However, in this method of precomplexation, the binding kinetics potentially limit the formation of HA precomplex at low HA concentrations (Ͻ5 g/ml). To accurately quantify the relative binding affinities, it is important to be able to measure binding of the precomplex at a lower concentration range (0.05 to 5 g/ml) (SI Fig. 8 ). Toward addressing this issue, the binding assay was modified by preparation of the precomplex at high HA concentration followed by serial dilution of the stock (as described above).
To quantify the binding affinity (for the above precomplexation assay), binding parameter K dЈ is defined and calculated based on the following model. The typical form of the Hill equation is used to represent the multivalent binding y ϭ ͓HA͔ n ͓HA͔ n ϩ KЈ d .
[1]
Linearizing Eq. 1 gives
where y is the fractional saturation of the glycan binding sites in the HA units; [HA] is the concentration of HA (in M); n is the cooperativity factor; and K dЈ is the apparent binding constant for the multivalent HA-glycan interactions. The value of y is calculated by normalizing the binding signals to the saturating binding signal, which represents 100% occupancy on all HA units. n and K dЈ were calculated based on the linearized Hill model (SI Fig. 7 ). An important assumption in the above model is that the glycans in each well of the plate are in excess of HA. To satisfy this assumption, the binding signals for HA concentration range from 0.05 to 5 g/ml was used to calculate n and KdЈ.
Binding of H1 HA to Human Upper Respiratory Tissues. Formalin-fixed and paraffin-embedded normal human tracheal tissue sections were purchased from US Biological. Tissue sections were deparaffinized, rehydrated, and preblocked with 1% BSA in PBS for 30 min at room temperature. HA-antibody precomplexes were generated by incubating recombinant SC18 and NY18 proteins with primary (mouse anti 6ϫ His tag; Abcam) and secondary (Alexa Fluor-488 goat anti-mouse IgG; Invitrogen) antibodies in a ratio of 4:2:1, respectively, for 20 min on ice. The complexes formed were then diluted in 1% BSA-PBS to different final HA concentrations. Tissue binding studies were performed by incubating tissue sections with the diluted HA-antibody complexes for 3 h at room temperature. To visualize the cell nuclei, sections were counterstained with propidium iodide (PI) (Invitrogen; 1:100 in TBST) for 20 min at room temperature. For costaining assays, tissues were deparaffinized, rehydrated, and coincubated with FITC-labeled Jacalin [Vector Labs; 10 g/ml in PBS with 0.05% Tween 20 (PBST)] and HA-antibody precomplexes (generated as described above with Alexa Fluor-546 goat anti-mouse IgG as secondary antibody and diluted in PBST) for 3 h at room temperature. Sections were then washed and viewed under a Zeiss LSM510 laser scanning confocal microscope.
